Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.010
+0.038 (3.95%)
At close: Oct 12, 2026, 4:00 PM EDT
1.010
0.00 (0.00%)
After-hours: Oct 12, 2026, 4:10 PM EDT
Marker Therapeutics Employees
Marker Therapeutics had 5 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes Marker Therapeutics the 41,741st largest employer in the world and 6,507th in the United States.
Employees
5
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$709,334
Profits / Employee
-$1,741,476
Market Cap
16.84M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 5 | 0 | - |
| Dec 31, 2024 | 5 | -3 | -37.50% |
| Dec 31, 2023 | 8 | -59 | -88.06% |
| Dec 31, 2022 | 67 | 11 | 19.64% |
| Dec 31, 2021 | 56 | 12 | 27.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| TScan Therapeutics | 138 |
| Palatin Technologies | 25 |
| Jasper Therapeutics | 22 |
| BioCardia | 21 |
| Kiora Pharmaceuticals | 13 |
| NewcelX | 12 |
| Psyence Biomedical | 12 |
| Actuate Therapeutics | 12 |
MRKR News
- 20 days ago - Marker Therapeutics highlights expanded manufacturing support of CDMO partner - TheFly
- 20 days ago - Marker Therapeutics Highlights Expanded Manufacturing Support of CDMO Partner Following Formation of Kincellis Advanced Therapies - GlobeNewsWire
- 1 month ago - Marker Therapeutics Quarterly report: Q2 2026 - Filings
- 4 months ago - Marker Therapeutics Quarterly report: Q1 2026 - Filings
- 6 months ago - Marker Therapeutics Proxy statement: Proxy filing - Filings
- 6 months ago - Marker Therapeutics Proxy statement: Proxy filing - Filings
- 6 months ago - Marker Therapeutics reports FY25 EPS (79c), two estimates (94c) - TheFly
- 6 months ago - Marker Therapeutics Reports Year-End 2025 Corporate and Financial Results - GlobeNewsWire